Tanner Pharma Group to Present at Bourne Partners 5th Annual Global Healthcare Executive Summit

Joshua Cooper to Moderate Healthcare Services Panel, “Changing Dynamics of Pharma Services”

 

CHARLOTTE, N.C., August 21, 2015 – Tanner Pharma Group will be largely showcased at the upcoming Bourne Partners Fifth Annual Global Healthcare Executive Summit on September 3, in Charlotte, North Carolina.

The conference, held at the internationally renowned Mint Museum, will feature top executives participating in a variety of panel discussions regarding healthcare and pharmaceutical issues and trends, as well as opportunities for attendees to interact one-on-one with industry leaders and innovators.

Conference attendees will include global healthcare and consumer executives from a variety of disciplines, including the pharmaceutical, hospital and healthcare technology sectors; private equity investors; and partners, investors, and clients of Bourne Partners and Tanner Pharma Group.

Joshua Cooper, Director of Corporate Development, will lead the Healthcare Services Panel, “Changing Dynamics of Pharma Services.”  Below is a representative list of panellists participating in the discussion:

David W. Bryant, Chairman and CEO of SeLux Diagnostics, Inc.

David Crane, Chairman and CEO of National Surgical Healthcare

Derek Hennecke, CEO and President of Xcelience

Michael Kane, CEO and Founder of Agilem Strategy, LLC.

“The panel is a great opportunity to showcase thought leaders in the healthcare services space and discuss opportunities in this rapidly evolving sector” said Mr. Cooper.

Tanner Pharma Group will also present a corporate overview highlighting recent hyper-growth and global expansion.

The two-day event is hosted by Bourne Partners, a leading healthcare and consumer-healthcare investment banking, merchant banking, and investment firm.

The fifth annual Bourne Partners Global Healthcare Executive Summit, featuring guest speaker, Jeff Gordon, a four-time NASCAR Series champion and presenters from leading pharmaceutical, pharma services, specialty pharma, biotech companies and investors, will take place Sept. 2-3 in Charlotte, N.C.

For additional information about Bourne Partners or the Bourne Partners Global Healthcare Executive Summit, please contact your Bourne Partners representative or Kristi Orange at 704-714-8367 or korange@bourne-partners.com.


About Tanner Pharma Group

For over 16 years, Tanner Pharma Group has partnered with biopharmaceutical companies to provide turn-key commercialization solutions to increase patient access to medicines around the world. By partnering with Tanner Pharma, biotech and pharma companies are able to focus on their primary markets while ensuring that patients in international markets of need are receiving their products through a strictly controlled channel.

Tanner Pharma believes that access to medicines should have no borders and measures its value as a company based on the lives it helps to improve. With an unparalleled blend of local market knowledge, international supply chain expertise across more than 130 countries, and high regulatory compliance and quality standards, it provides tailored solutions to biopharmaceutical companies outside their core markets of focus.

Headquartered in the U.S., Tanner’s reach includes Europe, Northeast Asia, Southeast Asia, the Middle East, Australia, Canada and Latin America, including Brazil, Mexico, the Caribbean, Central America and all of South America.

For more information about Tanner Pharma Group, please visit www.tannerpharma.com.

Contact Us